C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
GL Burnett, JB Aggen, J Pitzen - US Patent 12,048,749, 2024 - Google Patents
2022-08-10 Assigned to Revolution Medicines, Inc. reassignment Revolution Medicines, Inc.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
J Pitzen, GL Burnett, JB Aggen - US Patent 11,364,300, 2022 - Google Patents
2021-12-16 Assigned to Revolution Medicines, Inc. reassignment Revolution Medicines, Inc.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
Methods of treating cancer with an mTOR inhibitor
B Bitman, WC GUSTAFSON, E Lorenzana… - US Patent …, 2024 - Google Patents
2024-03-18 Assigned to Revolution Medicines, Inc. reassignment Revolution Medicines, Inc.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
C26-linked rapamycin analogs as mtor inhibitors
CM Semko, G Wang, GL Burnett, JB Aggen… - US Patent App. 18 …, 2024 - Google Patents
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical class C1C [C@@ H](O)[C@
H](OC) C [C@@ H] 1C [C@@ H](C)[C@ H] 1OC (= O)[C@@ H] 2CCCCN2C (= O) C …
H](OC) C [C@@ H] 1C [C@@ H](C)[C@ H] 1OC (= O)[C@@ H] 2CCCCN2C (= O) C …
C26-linked rapamycin analogs as mTOR inhibitors
CM Semko, G Wang, GL Burnett, JB Aggen… - US Patent …, 2023 - Google Patents
US11685749B2 - C26-linked rapamycin analogs as mTOR inhibitors - Google Patents
US11685749B2 - C26-linked rapamycin analogs as mTOR inhibitors - Google Patents C26-linked …
US11685749B2 - C26-linked rapamycin analogs as mTOR inhibitors - Google Patents C26-linked …